LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,212
تعداد مقالات11,057
تعداد مشاهده مقاله74,960,484
تعداد دریافت فایل اصل مقاله100,067,181
Ghasemi, Ziba, Farrokhi, Babak, Miraghasi, Farah, Ejaz Ahmad, Ardalan, Mosaffa, Nariman. (1385). Release of sFasL by Monocytes and Lymphocytes Triggered by Betaglucan and Zymosan. سامانه مدیریت نشریات علمی, 3(3), 121-126. doi: 10.22034/iji.2006.16985
Ziba Ghasemi; Babak Farrokhi; Farah Miraghasi; Ardalan Ejaz Ahmad; Nariman Mosaffa. "Release of sFasL by Monocytes and Lymphocytes Triggered by Betaglucan and Zymosan". سامانه مدیریت نشریات علمی, 3, 3, 1385, 121-126. doi: 10.22034/iji.2006.16985
Ghasemi, Ziba, Farrokhi, Babak, Miraghasi, Farah, Ejaz Ahmad, Ardalan, Mosaffa, Nariman. (1385). 'Release of sFasL by Monocytes and Lymphocytes Triggered by Betaglucan and Zymosan', سامانه مدیریت نشریات علمی, 3(3), pp. 121-126. doi: 10.22034/iji.2006.16985
Ghasemi, Ziba, Farrokhi, Babak, Miraghasi, Farah, Ejaz Ahmad, Ardalan, Mosaffa, Nariman. Release of sFasL by Monocytes and Lymphocytes Triggered by Betaglucan and Zymosan. سامانه مدیریت نشریات علمی, 1385; 3(3): 121-126. doi: 10.22034/iji.2006.16985

Release of sFasL by Monocytes and Lymphocytes Triggered by Betaglucan and Zymosan

Iranian Journal of Immunology
مقاله 4، دوره 3، شماره 3 - شماره پیاپی 10، آذر 2006، صفحه 121-126    اصل مقاله (70.05 K)
نوع مقاله: Original Article
شناسه دیجیتال (DOI): 10.22034/iji.2006.16985
نویسندگان
Ziba Ghasemi1؛ Babak Farrokhi1؛ Farah Miraghasi1؛ Ardalan Ejaz Ahmad2؛ Nariman Mosaffa* 1
1Department of Immunology, Faculty of Medicine, Shaheed Beheshti University of Medical Sciences, Tehran, Iran
2Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, Iran
چکیده
Background: Polysaccharides have long been used as immune-modulators in various pathologic conditions including inflammation and solid malignancies.
Objective: To evaluate the effects of Zymosan and Betaglucan on cytotoxic reactions in an effectortarget conjugate system.
Methods: Blood was obtained from 20 healthy subjects; purified mononuclear leukocytes (monocytes and lymphocytes) were extracted and cultured as effector cells by a cytotoxic method. Both adherent and non-adherent cells interacted with the K562 myeloid cell line. The effector-target (E:T) ratio was 1:1, 1:10, and 1:20. To evaluate stimulatory effects of Betaglucan and Zymosan on cytotoxic reactions, samples were divided into case and control groups based on the presence or absence of Betaglucan and Zymosan. MTT assay and sFas ligand (sFasL) concentrations were used to assess the increased killing capacity of effector cells.
Results: Our results revealed that Zymosan and Betaglucan can induce cytotoxic responses in macrophages and lymphocytes (P<0.05). The best result was achieved with E:T ratio of 1:1. Both macrophages and lymphocytes produced sFasL following stimulation by Zymosan and Betaglucan, however, the level of production was not statistically significant (P>0.05).
Conclusion: Zymosan and Betaglucan can be used as enhancers of the killing capacity of the immune cells; therefore, Betaglucan and Zymosan can be applied as systemic stimulators of the immune response in inflammation and chronic infection.
کلیدواژه‌ها
Effector-target Conjugate؛ Cytotoxic Reactions؛ macrophages؛ Lymphocytes؛ Zymosan؛ Betaglucan
آمار
تعداد مشاهده مقاله: 1,199
تعداد دریافت فایل اصل مقاله: 624


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب